glp 1 triple agonist Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset Retatrutide 10mg — Triple Receptor
Description
Post-marketing surveillance and case reports have documented instances of acute pancreatitis in patients taking these medications, prompting regulatory agencies to investigate the association
Liraglutide provides similar glycaemic control as glimepiride (both in combination with metformin) and reduces body weight and systolic blood pressure in Asian population with type 2 diabetes from China, South Korea and India: a 16-week, randomized, double-blind, active control trial(*)
Clinical obesity
Another way to approach this outcome would be to identify agonists that act on the GLP-1 receptor to produce the same pharmacological outcome
2025, doi: 10.1016/j.neurot.2025.e00712
The Journal of nutrition, 136(6), pp.1533-1538
